0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Drug Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-9M9244
Home | Market Reports
Global Veterinary Drug Market Outlook 2022
BUY CHAPTERS

Global Veterinary Drug Market Research Report 2026

Code: QYRE-Auto-9M9244
Report
2026-02-13
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Drug Market Size

The global Veterinary Drug market was valued at US$ 27690 million in 2025 and is anticipated to reach US$ 40060 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Veterinary Drug Market

Veterinary Drug Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Veterinary Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The growth of the veterinary drug market is primarily driven by the rising global demand for animal protein, such as meat, milk, and eggs, which necessitates improved animal health and productivity. Increasing pet ownership and heightened awareness of animal welfare are also contributing to greater demand for preventive and therapeutic veterinary treatments. Moreover, advancements in veterinary medicine—such as targeted antibiotics, vaccines, and parasiticides—are helping to address a wide range of animal diseases more effectively. Government initiatives and regulatory support for animal healthcare further strengthen the market, especially in emerging economies with expanding livestock and pet populations.
A major challenge in the veterinary drug market is the growing concern over antimicrobial resistance (AMR) resulting from the overuse and misuse of antibiotics in animals. Regulatory authorities are imposing stricter rules on drug approvals and usage, which can increase development costs and limit market accessibility for certain products. Additionally, the high cost and lengthy process of veterinary drug development—combined with the need for specialized R&D infrastructure—pose significant barriers to entry for smaller firms. Price sensitivity in developing regions and limited access to veterinary care in rural areas also hinder market penetration, particularly for premium or innovative drug formulations.
This report delivers a comprehensive overview of the global Veterinary Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Veterinary Drug. The Veterinary Drug market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Veterinary Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Veterinary Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Veterinary Drug Market Report

Report Metric Details
Report Name Veterinary Drug Market
Accounted market size in 2025 US$ 27690 million
Forecasted market size in 2032 US$ 40060 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
by Application
  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur, Jinhe Bio, Qianjiang Biochemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Veterinary Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Veterinary Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Veterinary Drug Market growing?

Ans: The Veterinary Drug Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Veterinary Drug Market size in 2032?

Ans: The Veterinary Drug Market size in 2032 will be US$ 40060 million.

Who are the main players in the Veterinary Drug Market report?

Ans: The main players in the Veterinary Drug Market are Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur, Jinhe Bio, Qianjiang Biochemical

What are the Application segmentation covered in the Veterinary Drug Market report?

Ans: The Applications covered in the Veterinary Drug Market report are Pets, Cattle, Poultry, Swine, Others

What are the Type segmentation covered in the Veterinary Drug Market report?

Ans: The Types covered in the Veterinary Drug Market report are Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others

1 Veterinary Drug Market Overview
1.1 Product Definition
1.2 Veterinary Drug by Type
1.2.1 Global Veterinary Drug Market Value by Type: 2025 vs 2032
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Veterinary Drug by Application
1.3.1 Global Veterinary Drug Market Value by Application: 2025 vs 2032
1.3.2 Pets
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Swine
1.3.6 Others
1.4 Global Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Veterinary Drug Revenue 2021–2032
1.4.2 Global Veterinary Drug Sales 2021–2032
1.4.3 Global Veterinary Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Veterinary Drug Market Competition by Manufacturers
2.1 Global Veterinary Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Veterinary Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Veterinary Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Veterinary Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Veterinary Drug, Product Types and Applications
2.7 Global Key Manufacturers of Veterinary Drug, Date of Entry into the Industry
2.8 Global Veterinary Drug Market Competitive Situation and Trends
2.8.1 Global Veterinary Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Veterinary Drug Players Market Share by Revenue
2.8.3 Global Veterinary Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Drug Market Scenario by Region
3.1 Global Veterinary Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Veterinary Drug Sales by Region: 2021–2032
3.2.1 Global Veterinary Drug Sales by Region: 2021–2026
3.2.2 Global Veterinary Drug Sales by Region: 2027–2032
3.3 Global Veterinary Drug Revenue by Region: 2021–2032
3.3.1 Global Veterinary Drug Revenue by Region: 2021–2026
3.3.2 Global Veterinary Drug Revenue by Region: 2027–2032
3.4 North America Veterinary Drug Market Facts & Figures by Country
3.4.1 North America Veterinary Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Veterinary Drug Sales by Country (2021–2032)
3.4.3 North America Veterinary Drug Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Drug Market Facts & Figures by Country
3.5.1 Europe Veterinary Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Veterinary Drug Sales by Country (2021–2032)
3.5.3 Europe Veterinary Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Veterinary Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Veterinary Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Drug Market Facts & Figures by Country
3.7.1 Latin America Veterinary Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Veterinary Drug Sales by Country (2021–2032)
3.7.3 Latin America Veterinary Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Veterinary Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Veterinary Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Drug Sales by Type (2021–2032)
4.1.1 Global Veterinary Drug Sales by Type (2021–2026)
4.1.2 Global Veterinary Drug Sales by Type (2027–2032)
4.1.3 Global Veterinary Drug Sales Market Share by Type (2021–2032)
4.2 Global Veterinary Drug Revenue by Type (2021–2032)
4.2.1 Global Veterinary Drug Revenue by Type (2021–2026)
4.2.2 Global Veterinary Drug Revenue by Type (2027–2032)
4.2.3 Global Veterinary Drug Revenue Market Share by Type (2021–2032)
4.3 Global Veterinary Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Veterinary Drug Sales by Application (2021–2032)
5.1.1 Global Veterinary Drug Sales by Application (2021–2026)
5.1.2 Global Veterinary Drug Sales by Application (2027–2032)
5.1.3 Global Veterinary Drug Sales Market Share by Application (2021–2032)
5.2 Global Veterinary Drug Revenue by Application (2021–2032)
5.2.1 Global Veterinary Drug Revenue by Application (2021–2026)
5.2.2 Global Veterinary Drug Revenue by Application (2027–2032)
5.2.3 Global Veterinary Drug Revenue Market Share by Application (2021–2032)
5.3 Global Veterinary Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis Veterinary Drug Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Company Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Elanco Veterinary Drug Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck Veterinary Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Ceva
6.6.1 Ceva Company Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ceva Veterinary Drug Product Portfolio
6.6.5 Ceva Recent Developments/Updates
6.7 Vetoquinol
6.7.1 Vetoquinol Company Information
6.7.2 Vetoquinol Description and Business Overview
6.7.3 Vetoquinol Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Vetoquinol Veterinary Drug Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Dechra
6.8.1 Dechra Company Information
6.8.2 Dechra Description and Business Overview
6.8.3 Dechra Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dechra Veterinary Drug Product Portfolio
6.8.5 Dechra Recent Developments/Updates
6.9 Norbrook
6.9.1 Norbrook Company Information
6.9.2 Norbrook Description and Business Overview
6.9.3 Norbrook Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Norbrook Veterinary Drug Product Portfolio
6.9.5 Norbrook Recent Developments/Updates
6.10 Phibro
6.10.1 Phibro Company Information
6.10.2 Phibro Description and Business Overview
6.10.3 Phibro Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Phibro Veterinary Drug Product Portfolio
6.10.5 Phibro Recent Developments/Updates
6.11 Huvepharma
6.11.1 Huvepharma Company Information
6.11.2 Huvepharma Description and Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments/Updates
6.12 Hipra
6.12.1 Hipra Company Information
6.12.2 Hipra Description and Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments/Updates
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Company Information
6.13.2 Ouro Fino Saude Description and Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments/Updates
6.14 CAHIC
6.14.1 CAHIC Company Information
6.14.2 CAHIC Description and Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments/Updates
6.15 Orion
6.15.1 Orion Company Information
6.15.2 Orion Description and Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments/Updates
6.16 Ringpu Biology
6.16.1 Ringpu Biology Company Information
6.16.2 Ringpu Biology Description and Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments/Updates
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Company Information
6.17.2 Nippon Zenyaku Kogyo Description and Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Company Information
6.18.2 Farmavet-Pasteur Description and Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments/Updates
6.19 Jinhe Bio
6.19.1 Jinhe Bio Company Information
6.19.2 Jinhe Bio Description and Business Overview
6.19.3 Jinhe Bio Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Jinhe Bio Veterinary Drug Product Portfolio
6.19.5 Jinhe Bio Recent Developments/Updates
6.20 Qianjiang Biochemical
6.20.1 Qianjiang Biochemical Company Information
6.20.2 Qianjiang Biochemical Description and Business Overview
6.20.3 Qianjiang Biochemical Veterinary Drug Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Qianjiang Biochemical Veterinary Drug Product Portfolio
6.20.5 Qianjiang Biochemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Drug Industry Chain Analysis
7.2 Veterinary Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Drug Production Mode & Process Analysis
7.4 Veterinary Drug Sales and Marketing
7.4.1 Veterinary Drug Sales Channels
7.4.2 Veterinary Drug Distributors
7.5 Veterinary Drug Customer Analysis
8 Veterinary Drug Market Dynamics
8.1 Veterinary Drug Industry Trends
8.2 Veterinary Drug Market Drivers
8.3 Veterinary Drug Market Challenges
8.4 Veterinary Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Drug Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Veterinary Drug Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Veterinary Drug Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Veterinary Drug Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Veterinary Drug Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Veterinary Drug Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Veterinary Drug Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Veterinary Drug Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Veterinary Drug, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Veterinary Drug, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Veterinary Drug, Product Types and Applications
 Table 12. Global Key Manufacturers of Veterinary Drug, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Drug Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Veterinary Drug Sales by Region (M Units), 2021–2026
 Table 18. Global Veterinary Drug Sales Market Share by Region (2021–2026)
 Table 19. Global Veterinary Drug Sales by Region (M Units), 2027–2032
 Table 20. Global Veterinary Drug Sales Market Share by Region (2027–2032)
 Table 21. Global Veterinary Drug Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Veterinary Drug Revenue Market Share by Region (2021–2026)
 Table 23. Global Veterinary Drug Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Veterinary Drug Revenue Market Share by Region (2027–2032)
 Table 25. North America Veterinary Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Veterinary Drug Sales by Country (M Units), 2021–2026
 Table 27. North America Veterinary Drug Sales by Country (M Units), 2027–2032
 Table 28. North America Veterinary Drug Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Veterinary Drug Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Veterinary Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Veterinary Drug Sales by Country (M Units), 2021–2026
 Table 32. Europe Veterinary Drug Sales by Country (M Units), 2027–2032
 Table 33. Europe Veterinary Drug Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Veterinary Drug Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Veterinary Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Veterinary Drug Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Veterinary Drug Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Veterinary Drug Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Veterinary Drug Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Veterinary Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Veterinary Drug Sales by Country (M Units), 2021–2026
 Table 42. Latin America Veterinary Drug Sales by Country (M Units), 2027–2032
 Table 43. Latin America Veterinary Drug Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Veterinary Drug Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Veterinary Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Veterinary Drug Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Veterinary Drug Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Veterinary Drug Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Veterinary Drug Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Veterinary Drug Sales (M Units) by Type (2021–2026)
 Table 51. Global Veterinary Drug Sales (M Units) by Type (2027–2032)
 Table 52. Global Veterinary Drug Sales Market Share by Type (2021–2026)
 Table 53. Global Veterinary Drug Sales Market Share by Type (2027–2032)
 Table 54. Global Veterinary Drug Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Veterinary Drug Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Veterinary Drug Revenue Market Share by Type (2021–2026)
 Table 57. Global Veterinary Drug Revenue Market Share by Type (2027–2032)
 Table 58. Global Veterinary Drug Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Veterinary Drug Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Veterinary Drug Sales (M Units) by Application (2021–2026)
 Table 61. Global Veterinary Drug Sales (M Units) by Application (2027–2032)
 Table 62. Global Veterinary Drug Sales Market Share by Application (2021–2026)
 Table 63. Global Veterinary Drug Sales Market Share by Application (2027–2032)
 Table 64. Global Veterinary Drug Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Veterinary Drug Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Veterinary Drug Revenue Market Share by Application (2021–2026)
 Table 67. Global Veterinary Drug Revenue Market Share by Application (2027–2032)
 Table 68. Global Veterinary Drug Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Veterinary Drug Price (USD/Unit) by Application (2027–2032)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Zoetis Veterinary Drug Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Elanco Company Information
 Table 76. Elanco Description and Business Overview
 Table 77. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Elanco Veterinary Drug Product
 Table 79. Elanco Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Boehringer Ingelheim Veterinary Drug Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Merck Veterinary Drug Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Virbac Veterinary Drug Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Ceva Company Information
 Table 96. Ceva Description and Business Overview
 Table 97. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Ceva Veterinary Drug Product
 Table 99. Ceva Recent Developments/Updates
 Table 100. Vetoquinol Company Information
 Table 101. Vetoquinol Description and Business Overview
 Table 102. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Vetoquinol Veterinary Drug Product
 Table 104. Vetoquinol Recent Developments/Updates
 Table 105. Dechra Company Information
 Table 106. Dechra Description and Business Overview
 Table 107. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Dechra Veterinary Drug Product
 Table 109. Dechra Recent Developments/Updates
 Table 110. Norbrook Company Information
 Table 111. Norbrook Description and Business Overview
 Table 112. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Norbrook Veterinary Drug Product
 Table 114. Norbrook Recent Developments/Updates
 Table 115. Phibro Company Information
 Table 116. Phibro Description and Business Overview
 Table 117. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Phibro Veterinary Drug Product
 Table 119. Phibro Recent Developments/Updates
 Table 120. Huvepharma Company Information
 Table 121. Huvepharma Description and Business Overview
 Table 122. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Huvepharma Veterinary Drug Product
 Table 124. Huvepharma Recent Developments/Updates
 Table 125. Hipra Company Information
 Table 126. Hipra Description and Business Overview
 Table 127. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Hipra Veterinary Drug Product
 Table 129. Hipra Recent Developments/Updates
 Table 130. Ouro Fino Saude Company Information
 Table 131. Ouro Fino Saude Description and Business Overview
 Table 132. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Ouro Fino Saude Veterinary Drug Product
 Table 134. Ouro Fino Saude Recent Developments/Updates
 Table 135. CAHIC Company Information
 Table 136. CAHIC Description and Business Overview
 Table 137. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. CAHIC Veterinary Drug Product
 Table 139. CAHIC Recent Developments/Updates
 Table 140. Orion Company Information
 Table 141. Orion Description and Business Overview
 Table 142. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Orion Veterinary Drug Product
 Table 144. Orion Recent Developments/Updates
 Table 145. Ringpu Biology Company Information
 Table 146. Ringpu Biology Description and Business Overview
 Table 147. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 148. Ringpu Biology Veterinary Drug Product
 Table 149. Ringpu Biology Recent Developments/Updates
 Table 150. Nippon Zenyaku Kogyo Company Information
 Table 151. Nippon Zenyaku Kogyo Description and Business Overview
 Table 152. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 153. Nippon Zenyaku Kogyo Veterinary Drug Product
 Table 154. Nippon Zenyaku Kogyo Recent Developments/Updates
 Table 155. Farmavet-Pasteur Company Information
 Table 156. Farmavet-Pasteur Description and Business Overview
 Table 157. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 158. Farmavet-Pasteur Veterinary Drug Product
 Table 159. Farmavet-Pasteur Recent Developments/Updates
 Table 160. Jinhe Bio Company Information
 Table 161. Jinhe Bio Description and Business Overview
 Table 162. Jinhe Bio Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 163. Jinhe Bio Veterinary Drug Product
 Table 164. Jinhe Bio Recent Developments/Updates
 Table 165. Qianjiang Biochemical Company Information
 Table 166. Qianjiang Biochemical Description and Business Overview
 Table 167. Qianjiang Biochemical Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 168. Qianjiang Biochemical Veterinary Drug Product
 Table 169. Qianjiang Biochemical Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Veterinary Drug Distributors List
 Table 173. Veterinary Drug Customers List
 Table 174. Veterinary Drug Market Trends
 Table 175. Veterinary Drug Market Drivers
 Table 176. Veterinary Drug Market Challenges
 Table 177. Veterinary Drug Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Drug
 Figure 2. Global Veterinary Drug Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Veterinary Drug Market Share by Type: 2025 & 2032
 Figure 4. Anti-Infectives Product Picture
 Figure 5. Anti-Inflammatory Product Picture
 Figure 6. Parasiticides Product Picture
 Figure 7. Analgesics Product Picture
 Figure 8. Sedatives Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Veterinary Drug Market Value by Application (US$ Million), 2021–2032
 Figure 11. Global Veterinary Drug Market Share by Application: 2025 & 2032
 Figure 12. Pets
 Figure 13. Cattle
 Figure 14. Poultry
 Figure 15. Swine
 Figure 16. Others
 Figure 17. Global Veterinary Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Veterinary Drug Market Size (US$ Million), 2021–2032
 Figure 19. Global Veterinary Drug Sales (M Units), 2021–2032
 Figure 20. Global Veterinary Drug Average Price (USD/Unit), 2021–2032
 Figure 21. Veterinary Drug Report Years Considered
 Figure 22. Veterinary Drug Sales Share by Manufacturers in 2025
 Figure 23. Global Veterinary Drug Revenue Share by Manufacturers in 2025
 Figure 24. Top 5 and Top 10 Global Veterinary Drug Players: Market Share by Revenue in Veterinary Drug in 2025
 Figure 25. Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Global Veterinary Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 27. North America Veterinary Drug Sales Market Share by Country (2021–2032)
 Figure 28. North America Veterinary Drug Revenue Market Share by Country (2021–2032)
 Figure 29. U.S. Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Canada Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Europe Veterinary Drug Sales Market Share by Country (2021–2032)
 Figure 32. Europe Veterinary Drug Revenue Market Share by Country (2021–2032)
 Figure 33. Germany Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. France Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. U.K. Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Italy Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Russia Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Asia Pacific Veterinary Drug Sales Market Share by Region (2021–2032)
 Figure 39. Asia Pacific Veterinary Drug Revenue Market Share by Region (2021–2032)
 Figure 40. China Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Japan Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. South Korea Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. India Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Australia Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Taiwan Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Indonesia Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Thailand Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Malaysia Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Philippines Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Latin America Veterinary Drug Sales Market Share by Country (2021–2032)
 Figure 51. Latin America Veterinary Drug Revenue Market Share by Country (2021–2032)
 Figure 52. Mexico Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Brazil Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Argentina Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Middle East and Africa Veterinary Drug Sales Market Share by Country (2021–2032)
 Figure 56. Middle East and Africa Veterinary Drug Revenue Market Share by Country (2021–2032)
 Figure 57. Turkey Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Saudi Arabia Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. UAE Veterinary Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Global Sales Market Share of Veterinary Drug by Type (2021–2032)
 Figure 61. Global Revenue Market Share of Veterinary Drug by Type (2021–2032)
 Figure 62. Global Veterinary Drug Price (USD/Unit) by Type (2021–2032)
 Figure 63. Global Sales Market Share of Veterinary Drug by Application (2021–2032)
 Figure 64. Global Revenue Market Share of Veterinary Drug by Application (2021–2032)
 Figure 65. Global Veterinary Drug Price (USD/Unit) by Application (2021–2032)
 Figure 66. Veterinary Drug Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS